• Article metrics
  • Last updated: Wed, 15 Oct 2025 8:33:16 Z

Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)

Access & Citations

  • 7900
    Article Accesses
  • 46
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 4
  • 2 tweeters
  • 78 Mendeley

This article is in the 63rd percentile (ranked 132,135th) of the 363,418 tracked articles of a similar age in all journals and the 40th percentile (ranked 39th) of the 67 tracked articles of a similar age in British Journal of Cancer

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.